Literature DB >> 24236985

Trehalose rescues Alzheimer's disease phenotypes in APP/PS1 transgenic mice.

Jing Du1, Yu Liang, Feng Xu, Bing Sun, Zhao Wang.   

Abstract

OBJECTIVE: Alzheimer's Disease (AD) is well characterized by the accumulated Aβ plaque in hippocampus and cerebral cortex concomitant with markedly reduced study and learning ability. Trehalose, a natural disaccharide, has been shown to have neural protective properties and exhibited therapeutic effects in animal models of several neural degenerative disorders. However, the effect of trehalose on AD pathology remains largely unknown.
METHODS: In this study, we evaluated the effects of trehalose in APP/PS1 transgenic mice through behaviour tests and biochemical analyses. KEY
FINDINGS: We found that the impaired cognitive and learning ability was improved and Aβ deposit in hippocampus was reduced.
CONCLUSIONS: These results suggested that trehalose could be a potential therapeutic drug for the treatment of AD.
© 2013 Royal Pharmaceutical Society.

Entities:  

Keywords:  biological evaluation of natural products; drugs from natural sources; molecular and clinical pharmacology; whole body pharmacology

Mesh:

Substances:

Year:  2013        PMID: 24236985     DOI: 10.1111/jphp.12108

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  45 in total

Review 1.  Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Authors:  Shu-Hui Xin; Lin Tan; Xipeng Cao; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2018-04-07       Impact factor: 3.911

Review 2.  The Mitochondrion: A Potential Therapeutic Target for Alzheimer's Disease.

Authors:  Mei-Hong Lu; Xiu-Yun Zhao; Pei-Pei Yao; De-En Xu; Quan-Hong Ma
Journal:  Neurosci Bull       Date:  2018-11-12       Impact factor: 5.203

Review 3.  Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Authors:  Barry Boland; Wai Haung Yu; Olga Corti; Bertrand Mollereau; Alexandre Henriques; Erwan Bezard; Greg M Pastores; David C Rubinsztein; Ralph A Nixon; Michael R Duchen; Giovanna R Mallucci; Guido Kroemer; Beth Levine; Eeva-Liisa Eskelinen; Fanny Mochel; Michael Spedding; Caroline Louis; Olivier R Martin; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

Review 4.  Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease.

Authors:  Masoomeh Khalifeh; George E Barreto; Amirhossein Sahebkar
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

Review 5.  Autophagy in neurodegenerative diseases: pathogenesis and therapy.

Authors:  Fang Guo; Xinyao Liu; Huaibin Cai; Weidong Le
Journal:  Brain Pathol       Date:  2017-08-06       Impact factor: 6.508

6.  Tailoring Trehalose for Biomedical and Biotechnological Applications.

Authors:  Mara K O'Neill; Brent F Piligian; Claire D Olson; Peter J Woodruff; Benjamin M Swarts
Journal:  Pure Appl Chem       Date:  2017-01-11       Impact factor: 2.453

Review 7.  Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.

Authors:  Lauren G Friedman; Yasir H Qureshi; Wai Haung Yu
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

8.  Orientin Improves Cognition by Enhancing Autophagosome Clearance in an Alzheimer's Mouse Model.

Authors:  Yi Zhong; Qing-Yu Zheng; Cheng-Yan Sun; Ze Zhang; Kun Han; Ning Jia
Journal:  J Mol Neurosci       Date:  2019-06-26       Impact factor: 3.444

9.  Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.

Authors:  Paola Rusmini; Katia Cortese; Valeria Crippa; Riccardo Cristofani; Maria Elena Cicardi; Veronica Ferrari; Giulia Vezzoli; Barbara Tedesco; Marco Meroni; Elio Messi; Margherita Piccolella; Mariarita Galbiati; Massimiliano Garrè; Elena Morelli; Thomas Vaccari; Angelo Poletti
Journal:  Autophagy       Date:  2018-11-05       Impact factor: 16.016

10.  Trehalose, an mTOR-Independent Inducer of Autophagy, Inhibits Human Cytomegalovirus Infection in Multiple Cell Types.

Authors:  Jean-Philippe Belzile; Maite Sabalza; Megan Craig; Alex Clark; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.